Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Grunfeld

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
British Journal of Clinical Pharmacology|February 1, 1993
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolaprilE G Bevan, G T McInnes, J C Aldigier, et al.
Journal De La Societe De Biologie|December 7, 2000
[Prevention of renal carcinoma: the nutri-genetic approach]C Junien, J M Dupret, C Gallou, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)B M Brenner, M E Cooper, D de Zeeuw, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
British Journal of Clinical Pharmacology|February 1, 1993
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolaprilE G Bevan, G T McInnes, J C Aldigier, et al.
Journal De La Societe De Biologie|December 7, 2000
[Prevention of renal carcinoma: the nutri-genetic approach]C Junien, J M Dupret, C Gallou, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)B M Brenner, M E Cooper, D de Zeeuw, et al.
Pageof 3